Tirzepatide-induced weight loss and obstructive sleep apnea improvement in an adult with type 2 diabetes: A case report
In selected adults with T2DM and OSA, tirzepatide-associated weight loss may contribute to device-monitored control of OSA on CPAP, enabling supervised withdrawal in carefully selected cases. While single-patient observations cannot establish causality, they complement emerging evidence and can guide patient counseling and hypothesis generation for prospective studies.
Authors
- Tsunemichi Hirose
- Naotake Funamizu (ORCID: https://orcid.org/0000-0001-6076-6516)
- Noriko Funamizu
Institutions
- Ehime Medical Center (JP)
- Funabashi Orthopaedic Hospital (JP)
Publication Details
- Journal
- Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1097/md.0000000000045445
- Primary Topic
- Obstructive Sleep Apnea Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00